UCLA Hematology/Oncology- Westlake — Westlake Village, California

UCLA Hematology/Oncology- Westlake is a clinical research site located in Westlake Village, California, United States 91361.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

UCLA Hematology/Oncology- Westlake has participated in 8 clinical trials with 5 currently active.

Therapeutic areas: Breast Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer.

Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer, Hoffmann-La Roche.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Westlake Village

Browse all research sites in California · View every site in Westlake Village

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Hematology/Oncology- Westlake?

UCLA Hematology/Oncology- Westlake has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Hematology/Oncology- Westlake conducted?

UCLA Hematology/Oncology- Westlake has 8 clinical trials on record, with 5 currently active. Their work covers Breast Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer.

Is UCLA Hematology/Oncology- Westlake accredited by Crixeo Clinical Trials?

UCLA Hematology/Oncology- Westlake has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Hematology/Oncology- Westlake?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.